Ruti Aga Banned Six Years: Four of Them for a Forged Prescription From a Clinic That Never Existed

There is a name on the document. The clinic does not exist. The signature belongs to a family member with no medical registration, who claimed to have used an old prescription pad from a former workplace — a workplace that later confirmed in writing she had never been on its staff list. Three layers of verification, three failures. That is the file the Athletics Integrity Unit (AIU) published, and it is why a marathoner who once won Tokyo is serving a six-year ban, effective from 10 September.

Ruti Aga, 32, of Ethiopia. The sanction has two parts: two years for the presence of methylprednisolone in her sample, four years for tampering with evidence. They are added, not offset. Most summaries skip that detail and report "athlete banned six years for doping".

Every press room holds two stories: one that gets read aloud, one you have to go and find.

Context: a paid appearance, a problematic knee

In 2026, Aga won the Tokyo Marathon. Around that period she also finished runner-up three times at World Marathon Majors. The official statement does not name which three, so I record it only as career context. Across the 2026–2026 window, that is the profile of an athlete in the leading group of women's road running, not the reserve pool.

The triggering result came at a half marathon in China, in March. No performance mark was disclosed. Without a time, the race cannot be positioned against course records or her personal best, so any inference about its sporting significance is inference — and I leave it there. What remains is market structure: Chinese road races pay appearance fees, and the flow of East African athletes through them is a stable feature of the professional marathon economy.

Jurisdiction sat with the AIU, World Athletics' independent integrity body, from testing through results management to prosecution, resolved under the WADA Code rather than a race organiser's rules. That boundary matters: a Chinese half marathon may be the collection point, but the adjudication sits at federation level.

Aga attributed the positive to treatment for a knee injury. At 32 she was inside the elite marathon peak window, not past it. The ban lands at the point of maximum career value.

Core: methylprednisolone is not an anabolic steroid

A technical correction many reports got wrong: methylprednisolone is a synthetic glucocorticoid — a corticosteroid — not an anabolic-androgenic steroid. Under WADA classification it sits in class S9, prohibited in-competition only, and is designated a Specified Substance. Those three facts reshape the case.

Class S9 applies in-competition, so route and timing determine whether a violation exists at all. Specified Substances are those more plausibly linked to therapeutic or inadvertent use, carrying a two-year baseline rather than four. And with a valid TUE, a genuine knee treatment would in principle create no violation.

The substance side of this case was always the soft half. The paperwork was the hard half.

The sanction arithmetic shows it. Four years for the forgery exceeds two years for the prohibited substance. Under the WADA Code, tampering during results management is an independent violation with a four-year baseline, and multiple violations are served consecutively, not concurrently. An honest declaration of a two-year therapeutic misadventure could have closed at a far lower figure — possibly at zero.

The AIU file has no gaps: the clinic denied the prescription, confirmed the signatory was never on staff, and the regulator confirmed no medical registration. Three independent sources pointing one way. Based on my experience tracking testing and results management, this is the kind of file a competent lawyer tells a client to accept immediately, because the evidence leaves no exit.

One procedural note: with a tampering finding, retrospective review of earlier samples — including biological passport data — is procedurally live, though the statement does not raise it. It does not lengthen the ban, but it is why interference cases often pull several seasons back into scope.

Contrarian: the sentence was not for doping

The common reading — another cheat caught — misses the point. What was punished more heavily here was the paper, not the injection. And because of that, this is a case about institutional capacity more than individual morality.

Everyone reads the transfer list. I read the medical file before that list goes to print.

Look at the mechanics: a relative, an old prescription pad, an imaginary clinic. The mechanism carries the signature of an amateur cover-up run by people with no compliance expertise. That amateurism is itself diagnostic: the medical and legal support around this athlete was too thin.

Very few athletes in the East African road-running pipeline retain dedicated compliance counsel. A corticosteroid course close to a race, no TUE, no declaration — a common and fixable error. What is not fixable is the next reflex: reaching for documents instead of disclosure. Team doctors do not treat one race; they treat the seasons ahead. Here, nobody played that role.

An injury case is a test: does the system trust the person or the process? Whether Aga held a TUE, whether anyone read class S9 rules with her — the file is silent, and that is the more useful question.

7 June 2026 — the day I stopped trusting instinct and started trusting data. The lesson holds: data does not judge, but data does not excuse either. A positive sample and a forged prescription are two different lines of data, and only the second turned an error into six years.

What remains

The ban runs from 10 September for six years. Aga becomes eligible again at roughly 38. Female marathoners can compete at the top into their late thirties, but the probability of returning to World Marathon Majors podium level after a six-year layoff is very low. The March result is almost certainly annulled, with prize money forfeited. Sponsorship contracts typically carry morality clauses, and a "fake doctor in the family" narrative outlives the sanction itself.

For the Ethiopian women's road pipeline, this is a replaceable node. The depth is such that one removal from the leading group barely registers on the national results board. For a 32-year-old athlete, it is the rest of a career.

The notable figure is the gap between two years and six — a gap created by a decision taken in a few hours, at the exact moment someone should have said: tell the truth, we handle the rest. Athletics has spent heavily on detection. It still spends very little on the person sitting beside the athlete in that moment.